Renal pharmacotherapy : dosage adjustment of medications eliminated by the kidneys / Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H, Kiser, Gerard R. Barber, Nancy M. Stolpman.
Golightly, Larry K., author.; Teitelbaum, Isaac, author.; Simendinger, Bonita A., author.; Kiser, Tyree H., author.; Barber, Gerard R., author.; Stolpman, Nancy M., author.
2021
RM145 .G65 2021
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Renal pharmacotherapy : dosage adjustment of medications eliminated by the kidneys / Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H, Kiser, Gerard R. Barber, Nancy M. Stolpman.
Author
Golightly, Larry K., author.
Edition
Second edition.
ISBN
9783030586508 (electronic bk.)
3030586502 (electronic bk.)
9783030586492
3030586499
DOI
https://doi.org/10.1007/978-3-030-58650-8
Published
Cham : Springer, [2021]
Copyright
©2021
Language
English
Description
1 online resource : illustrations
Item Number
10.1007/978-3-030-58650-8 doi
Call Number
RM145 .G65 2021
Dewey Decimal Classification
615.1/9
Summary
To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed October 1, 2021).
Added Author
Teitelbaum, Isaac, author.
Simendinger, Bonita A., author.
Kiser, Tyree H., author.
Barber, Gerard R., author.
Stolpman, Nancy M., author.
Available in Other Form
Renal pharmacotherapy.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
A: Acamprosate to Aztreonam
B: Bacitracin to Butorphanol
: Capecitabine to Cycloserine
D: Dabigatran to Dyphylline
E: Edetate Calcium Disodium to Exenatide
F: Famciclovir to Fosfomycin
H: Hetastarch to Hydroxyurea
I: Ibandronate to Itraconazole
K: Kanamycin to Ketorolac
L: Lacosamide to Lurasidone
M: Magnesium Citrate to Mycophenolate Mofetil
N: Nabumetone to Norfloxacin
O: Ofloxacin to Oxcarbazepine
P: Paliperidone to Pyridostigmine
Q: Quinapril to Quinine
R: Ramipril to Ruxolitinib
S: Salsalate to Sunitinib
T: Tadalafil to Trospium
V: Valacyclovir to Voriconazole
Z: Zalcitabine to Zonisamide
Proprietary Name Index.

Browse Subjects

Show more subjects...

Statistics

from
to
Export